Overview

Hypoactive Sexual Desire Disorder in Males

Status:
Recruiting

Trial end date:
2025-10-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if the study drug will increase sexual desire in men with HSDD. Half of the participants will take ADDYI while the other half will receive a placebo (a look-alike pill with no medicine).

Phase:

Phase 2

Details

Lead Sponsor:

Mohit Khera

Collaborator:

Sprout Pharmaceuticals, Inc